Harmony Biosciences Holdings, Inc. Common Stock (HRMY)
PHARMACEUTICAL PREPARATIONS
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is listed on Nasdaq, where it has traded since August 19, 2020.
- Listed On
- Nasdaq
- Listed Since
- August 19, 2020
- Employees
- 293
- Market Cap
- $2.3B
About Harmony Biosciences Holdings, Inc. Common Stock
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 317 institutions reported holding HRMY, with 54.1 million shares worth $2.0 billion in aggregate. The largest reported holder was BlackRock, with 7.1 million shares worth $258.6 million. Of the 5 largest holders listed below, all 5 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 7,101,965 | $259M | Added 0.45% |
| Vanguard | 5,372,371 | $196M | Added 3.77% |
| FMR | 3,574,115 | $130M | Added 13.19% |
| American Century Companies | 2,539,512 | $92M | Added 20.63% |
| Dimensional Fund Advisors | 2,393,588 | $87M | Added 15.27% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is HRMY?
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is listed on Nasdaq, where it has traded since August 19, 2020.
Who are the largest institutional holders of HRMY?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of HRMY were BlackRock, Vanguard and FMR.
How many institutions own HRMY?
317 institutions reported a position in HRMY for the quarter ended June 30, 2026, worth $2.0 billion in total.
Did institutions buy or sell HRMY last quarter?
Of the 5 largest reported holders, all 5 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for HRMY.
Every reported institutional holder, plus insider and congressional trades in HRMY, on SentiSense.